Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
Fucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysac...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/16/4/132 |
_version_ | 1828352883714686976 |
---|---|
author | Olga N. Pozharitskaya Alexander N. Shikov Natalya M. Faustova Ekaterina D. Obluchinskaya Vera M. Kosman Heikki Vuorela Valery G. Makarov |
author_facet | Olga N. Pozharitskaya Alexander N. Shikov Natalya M. Faustova Ekaterina D. Obluchinskaya Vera M. Kosman Heikki Vuorela Valery G. Makarov |
author_sort | Olga N. Pozharitskaya |
collection | DOAJ |
description | Fucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysaccharide found in Fucus (F.) vesiculosus. The pharmacokinetic profiling of active compounds is essential for drug development and approval. The aim of the study was to evaluate the pharmacokinetics and tissue distribution of fucoidan in rats after a single-dose oral administration. Fucoidan was isolated from F. vesiculosus. The method of measuring anti-activated factor X (anti-Xa) activity by amidolytic assay was used to analyze the plasma and tissue concentrations of fucoidan. The tissue distribution of fucoidan after intragastric administration to the rats was characterized, and it exhibited considerable heterogeneity. Fucoidan preferentially accumulates in the kidneys (AUC0–t = 10.74 µg·h/g; Cmax = 1.23 µg/g after 5 h), spleen (AUC0–t = 6.89 µg·h/g; Cmax = 0.78 µg/g after 3 h), and liver (AUC0–t = 3.26 µg·h/g; Cmax = 0.53 µg/g after 2 h) and shows a relatively long absorption time and extended circulation in the blood, with a mean residence time (MRT) = 6.79 h. The outcome of this study provides additional scientific data for traditional use of fucoidan-containing plants and offers tangible support for the continued development of new effective pharmaceuticals using fucoidan. |
first_indexed | 2024-04-14T01:59:31Z |
format | Article |
id | doaj.art-eaff93a032a6469da7a4b3f5927e2136 |
institution | Directory Open Access Journal |
issn | 1660-3397 |
language | English |
last_indexed | 2024-04-14T01:59:31Z |
publishDate | 2018-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Marine Drugs |
spelling | doaj.art-eaff93a032a6469da7a4b3f5927e21362022-12-22T02:18:53ZengMDPI AGMarine Drugs1660-33972018-04-0116413210.3390/md16040132md16040132Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to RatsOlga N. Pozharitskaya0Alexander N. Shikov1Natalya M. Faustova2Ekaterina D. Obluchinskaya3Vera M. Kosman4Heikki Vuorela5Valery G. Makarov6Saint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaRMC “House of Pharmacy”, Leningrad Region, Vsevolozhsky District, Zavodskaya str., 3, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaFederal State Budgetary Scientific Institution of Murmansk Marine Biological Institute, Kola Scientific Center of the Russian Academy of Sciences (MMBI KSC RAS), Vladimirskaya, 17, 183010 Murmansk, RussiaSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, FinlandSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaFucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysaccharide found in Fucus (F.) vesiculosus. The pharmacokinetic profiling of active compounds is essential for drug development and approval. The aim of the study was to evaluate the pharmacokinetics and tissue distribution of fucoidan in rats after a single-dose oral administration. Fucoidan was isolated from F. vesiculosus. The method of measuring anti-activated factor X (anti-Xa) activity by amidolytic assay was used to analyze the plasma and tissue concentrations of fucoidan. The tissue distribution of fucoidan after intragastric administration to the rats was characterized, and it exhibited considerable heterogeneity. Fucoidan preferentially accumulates in the kidneys (AUC0–t = 10.74 µg·h/g; Cmax = 1.23 µg/g after 5 h), spleen (AUC0–t = 6.89 µg·h/g; Cmax = 0.78 µg/g after 3 h), and liver (AUC0–t = 3.26 µg·h/g; Cmax = 0.53 µg/g after 2 h) and shows a relatively long absorption time and extended circulation in the blood, with a mean residence time (MRT) = 6.79 h. The outcome of this study provides additional scientific data for traditional use of fucoidan-containing plants and offers tangible support for the continued development of new effective pharmaceuticals using fucoidan.http://www.mdpi.com/1660-3397/16/4/132anti-Xa activityFucus vesiculosusfucoidankidneysliverpharmacokineticspleen |
spellingShingle | Olga N. Pozharitskaya Alexander N. Shikov Natalya M. Faustova Ekaterina D. Obluchinskaya Vera M. Kosman Heikki Vuorela Valery G. Makarov Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats Marine Drugs anti-Xa activity Fucus vesiculosus fucoidan kidneys liver pharmacokinetic spleen |
title | Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats |
title_full | Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats |
title_fullStr | Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats |
title_full_unstemmed | Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats |
title_short | Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats |
title_sort | pharmacokinetic and tissue distribution of fucoidan from fucus vesiculosus after oral administration to rats |
topic | anti-Xa activity Fucus vesiculosus fucoidan kidneys liver pharmacokinetic spleen |
url | http://www.mdpi.com/1660-3397/16/4/132 |
work_keys_str_mv | AT olganpozharitskaya pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT alexandernshikov pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT natalyamfaustova pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT ekaterinadobluchinskaya pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT veramkosman pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT heikkivuorela pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats AT valerygmakarov pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats |